Presentation Information
[2P-852]Synergistic targeting of the ARID2-MYC axis by IMiDs and HDAC Inhibitors overcomes intrinsic IMiDs resistance in multiple myeloma cell
○Junichi Yamamoto1, Tomoko Asatsuma-Okumura2, Takumi Ito3, Yoshiko Iwai2, Hiroshi Handa3, Yuki Yamaguchi1 (1. Tokyo Institute of Science, 2. Nippon Medical School, 3. Tokyo Medical University)
Comment
To browse or post comments, you must log in.Log in